Precision 3D Printing for Semi Solid Materials and Medicine

In conventional manufacturing, three-dimensional printing typically focuses on rigid thermoplastic filaments and metallic powders. However, biological research and pharmaceutical laboratories require far softer, more sensitive substances to produce viable tissues and custom treatments. Hydrogels, ceramic pastes, and living bioinks demand high mechanical stability and gentle extrusion mechanisms to create complex architectures without damaging delicate cellular structures. Bruna Manzini identified that off-the-shelf equipment and standard slicing software were rarely optimised for such pseudoplastic materials. To solve this challenge, 593iCAN 3D Printing Solutions was established in the technology hub of Campinas, Brazil, creating an integrated ecosystem designed explicitly for semi-solid bio-fabrication.

The physical foundation of the company's approach rests upon its specialised hardware platform designed specifically for soft material handling. The flagship +593 3D printer line incorporates precision linear guides and heavy-duty slide blocks to maintain exceptional structural rigidity during intricate print cycles. At the centre of the machine lies a dual extrusion head powered by robust motors delivering five kilograms-force centimetre of torque. Designed to work with standard ten-millilitre disposable syringes, this mechanism provides exact, controlled deposition of gels, hydrogels, and ceramic pastes. This precise motor control ensures that sensitive biological compounds can be extruded reliably across extended production runs.

Hardware capabilities are closely matched by BioScaffolds, the proprietary software platform developed in-house by 593iCAN. Creating machine instructions for bio-fabrication historically required cumbersome manual adjustments or adaptations of generic industrial slicing tools. BioScaffolds addresses this inefficiency by rapidly generating tailored G-code designed for delicate scaffold geometries, drastically reducing setup times for academic and medical researchers. In addition to its native features, the software remains compatible with various open-source three-dimensional printing applications. This open compatibility gives interdisciplinary research teams the freedom to integrate the tool directly into their existing lab workflows without friction.

The practical uses for this hardware and software combination cover a broad spectrum of medical, pharmaceutical, and scientific research. In tissue engineering, laboratories rely on the system to print three-dimensional biological scaffolds that assist in cellular growth and tissue regeneration. In pharmaceutical research, the equipment enables the precise fabrication of personalised drug delivery systems tailored to individual patient requirements. The platform also handles smart materials and advanced pastes, extending its utility into material science and interdisciplinary industrial applications. By uniting physical accuracy with intuitive digital tools, the platform provides high reproducibility across demanding research trials.

As global interest in personalized medicine and advanced bio-fabrication grows, the Brazilian deep tech company is preparing for broader international expansion. Operating from Campinas, the team combines internal research and development with scalable manufacturing and structured quality control standards. 593iCAN 3D Printing Solutions will present its technology at Web Summit 2026, building on its international presence following participation at Hannover Messe 2026. Through these global appearances, the company aims to connect with international healthcare leaders and research institutions seeking reliable tools for semi-solid material fabrication.

Find out more at 593ican.com.br